Added to YB: 2026-08-26
Pitch date: 2026-08-20
ZTS [neutral]
Zoetis Inc.
+2.66%
current return
Author Info
No bio for this author
Company Info
Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic tests, and precision animal health solutions for the animal health industry in the United States and internationally.
Market Cap
$32.1B
Pitch Price
$75.29
Price Target
N/A
Dividend
2.73%
EV/EBITDA
9.48
P/E
12.68
EV/Sales
4.17
Sector
Pharmaceuticals
Category
value
The market punishes, my algorithm hunts: 17 potential opportunities in the S&P 500 - Zoetis Inc.
ZTS (quick overview): Global animal-health leader trading ~60% off its peak even as earnings kept rising—a price-driven dislocation in a structurally growing market (pet humanization, vaccines, diagnostics). Author's algo scores it 94. Key watch item: ROIC is trending down—thesis hinges on whether that's cyclical or structural.
Read full article (1 min)